← Human Trials & Peer-Reviewed Studies

Small-quantity lipid-based nutrient supplements, with or without added zinc, do not cause excessive fat deposition in Burkinabe children: results from a cluster-randomized community trial.

Plain-language guide to PMID 35829783 (2022): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
35829783
Journal
European journal of nutrition
Year
2022
Study type
Randomized Controlled Trial
Authors
Abbeddou S et al. (6 authors)
DOI
10.1007/s00394-022-02936-6
Registered trial
NCT00944281

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

Public health interventions to address stunting and wasting should be evaluated for possibly contributing to obesity risk.

A mixed linear model was used to examine average change in FFM and % fat mass (%FM) among intervention groups and by cohort.

Who Took Part

The age groups tagged for this paper are infants, young children and children.

Body composition was assessed in a subset of IC (n = 201) and NIC (n = 74) children at 9 and 18 months using the deuterium dilution method.

How the Study Was Run

The researchers set it up as a randomized study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

The subject headings attached to it are Deuterium, Dietary Supplements, Lipids, Nutrients and Zinc.

The authors tagged it with the keywords Body composition, Child, Deuterium dilution technique, Fat mass, Fat-free mass and Small-quantity lipid-based nutrient supplements.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2022 (European journal of nutrition), a journal based in Germany.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.